報價延遲最少15分鐘:2026/11/04 20:57 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.69 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.90/1.10
|
|
企業價值
1.43M
|
| 資產負債 |
|
每股賬面淨值
26.81
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
0.16
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Niki BioSolutions Inc is a clinical-stage life sciences company focused on unmet medical needs and providing genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations. Its activities include the development and application of proprietary technologies to support precision medicine across therapeutic areas including brain health and oncology. The company also collaborates with academic centers, disease foundations, and biopharmaceutical companies. |
